| African American men with very low–risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them? D Sundi, AE Ross, EB Humphreys, M Han, AW Partin, HB Carter, ... Journal of clinical oncology 31 (24), 2991, 2013 | 259 | 2013 |
| A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy AE Ross, FY Feng, M Ghadessi, N Erho, A Crisan, C Buerki, D Sundi, ... Prostate cancer and prostatic diseases 17 (1), 64-69, 2014 | 153 | 2014 |
| Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men D Sundi, ON Kryvenko, HB Carter, AE Ross, JI Epstein, EM Schaeffer The Journal of urology 191 (1), 60-67, 2014 | 149 | 2014 |
| BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCG AM Kamat, M Colombel, D Sundi, D Lamm, A Boehle, M Brausi, ... Nature Reviews Urology 14 (4), 244-255, 2017 | 141 | 2017 |
| Very-high-risk localized prostate cancer: definition and outcomes D Sundi, VM Wang, PM Pierorazio, M Han, TJ Bivalacqua, MW Ball, ... Prostate cancer and prostatic diseases 17 (1), 57-63, 2014 | 110 | 2014 |
| Racial variations in prostate cancer molecular subtypes and androgen receptor signaling reflect anatomic tumor location FA Faisal, D Sundi, JJ Tosoian, V Choeurng, M Alshalalfa, AE Ross, ... European urology 70 (1), 14-17, 2016 | 89 | 2016 |
| Prevalence and prognostic significance of PTEN loss in African-American and European-American men undergoing radical prostatectomy JJ Tosoian, F Almutairi, CL Morais, S Glavaris, J Hicks, D Sundi, ... European urology 71 (5), 697-700, 2017 | 76 | 2017 |
| Reclassification rates are higher among African American men than Caucasians on active surveillance D Sundi, FA Faisal, BJ Trock, PK Landis, Z Feng, AE Ross, HB Carter, ... Urology 85 (1), 155-160, 2015 | 76 | 2015 |
| Racial disparities in oncologic outcomes after radical prostatectomy: long-term follow-up FA Faisal, D Sundi, JL Cooper, EB Humphreys, AW Partin, M Han, ... Urology 84 (6), 1434-1441, 2014 | 72 | 2014 |
| Upper tract urothelial carcinoma: impact of time to surgery D Sundi, RS Svatek, V Margulis, CG Wood, SF Matin, CP Dinney, ... Urologic Oncology: Seminars and Original Investigations 30 (3), 266-272, 2012 | 60 | 2012 |
| Establishment of a new prostate cancer multidisciplinary clinic: format and initial experience D Sundi, JE Cohen, AP Cole, BP Neuman, J Cooper, FA Faisal, AE Ross, ... The Prostate 75 (2), 191-199, 2015 | 56 | 2015 |
| Pathologic outcomes in favorable-risk prostate cancer: comparative analysis of men electing active surveillance and immediate surgery JJ Tosoian, D Sundi, BJ Trock, P Landis, JI Epstein, EM Schaeffer, ... European urology 69 (4), 576-581, 2016 | 54 | 2016 |
| Outcomes of very high‐risk prostate cancer after radical prostatectomy: validation study from 3 centers D Sundi, JJ Tosoian, YA Nyame, R Alam, M Achim, CA Reichard, J Li, ... Cancer 125 (3), 391-397, 2019 | 49 | 2019 |
| Risk of pathological upgrading and up staging among men with low risk prostate cancer varies by race: results from the National Cancer Database MJ Maurice, D Sundi, EM Schaeffer, R Abouassaly The Journal of urology 197 (3), 627-631, 2017 | 46 | 2017 |
| Laparoscopic and robotic radical prostatectomy outcomes in obese and extremely obese men D Sundi, AC Reese, LZ Mettee, BJ Trock, CP Pavlovich Urology 82 (3), 600-605, 2013 | 44 | 2013 |
| Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cells AR Metwalli, S Khanbolooki, G Jinesh, D Sundi, JB Shah, M Shrader, ... Cancer biology & therapy 10 (9), 885-892, 2010 | 44 | 2010 |
| Germline variants in asporin vary by race, modulate the tumor microenvironment, and are differentially associated with metastatic prostate cancer PJ Hurley, D Sundi, B Shinder, BW Simons, RM Hughes, RM Miller, ... Clinical cancer research 22 (2), 448-458, 2016 | 37 | 2016 |
| Is active surveillance a suitable option for African American men with prostate cancer? A systemic literature review MI Gökce, D Sundi, E Schaeffer, C Pettaway Prostate Cancer and Prostatic Diseases 20 (2), 127-136, 2017 | 30 | 2017 |
| Utility of risk models in decision making after radical prostatectomy: lessons from a natural history cohort of intermediate-and high-risk men AE Ross, K Yousefi, E Davicioni, M Ghadessi, MH Johnson, D Sundi, ... European Urology 69 (3), 496-504, 2016 | 30 | 2016 |
| Identification of men with the highest risk of early disease recurrence after radical prostatectomy D Sundi, V Wang, PM Pierorazio, M Han, AW Partin, PT Tran, AE Ross, ... The Prostate 74 (6), 628-636, 2014 | 26 | 2014 |
Edward M Schaeffer, MD PhDNorthwestern UniversityVerified email at northwestern.edu
